From: Effects of lornoxicam on the physiology of severe sepsis
Parameter | Baseline | Hours after the start of infusion | ||
---|---|---|---|---|
24 | 48 | 72 | ||
Lactate (mg/dl) | ||||
Lornoxicam | 25.2 ± 4.1 | 25.0 ± 3.9 | 25.9 ± 5.2 | 26.2 ± 3.7 |
Placebo | 26.3 ± 3.8 | 26.7 ± 2.9 | 27.0 ± 3.1 | 26.9 ± 4.8 |
Platelets (×109/l) | ||||
Lornoxicam | 192.9 ± 16.5 | 193.5 ± 15.0 | 178.1 ± 15.4 | 182.9 ± 15.6 |
Placebo | 188.5 ± 14.4 | 190.8 ± 15.1 | 188.7 ± 13.3 | 190.5 ± 16.7 |
Leucocytes (×109/l) | ||||
Lornoxicam | 14 ± 8.3 | 15.8 ± 8.3 | 16.0 ± 7.8 | 15.9 ± 6.2 |
Placebo | 13.5 ± 6.6 | 14.7 ± 4.7 | 15.7 ± 6.7 | 14.8 ± 7.4 |
Bilirubin (mg/dl) | ||||
Lornoxicam | 0.89 ± 0.38 | 0.90 ± 0.45 | 0.93 ± 0.33 | 0.90 ± 0.34 |
Placebo | 0.90 ± 0.62 | 0.91 ± 0.38 | 0.92 ± 0.28 | 0.91 ± 0.36 |
Alanine aminotransferase (IU/l) | ||||
Lornoxicam | 35.4 ± 5.5 | 36.0 ± 10.8 | 35.1 ± 8.6 | 36.7 ± 8.4 |
Placebo | 35.4 ± 7.4 | 35.5 ± 5.2 | 36.2 ± 6.0 | 37.4 ± 4.9 |
Creatinine (mg/dl) | ||||
Lornoxicam | 1.13 ± 0.96 | 1.15 ± 0.85 | 1.2 ± 0.3 | 1.28 ± 0.8 |
Placebo | 1.01 ± 0.91 | 1.1 ± 0.65 | 1.08 ± 0.7 | 1.1 ± 0.8 |